Andrew R. Mcdonald - 23 Feb 2024 Form 4 Insider Report for Cushman & Wakefield plc (CWK)

Role
Global President & Chief Operating Officer Exhibit 24 - Power of Attorney
Signature
/s/ Noelle J. Perkins, attorney-in-fact
Issuer symbol
CWK
Transactions as of
23 Feb 2024
Net transactions value
-$433,936
Form type
4
Filing time
27 Feb 2024, 16:35:45 UTC
Previous filing
15 Aug 2023
Next filing
29 Feb 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CWK Ordinary Shares Options Exercise $0 +34,878 +20% $0.000000 210,758 23 Feb 2024 Direct F1
transaction CWK Ordinary Shares Tax liability $119,902 -12,210 -5.8% $9.82 198,548 23 Feb 2024 Direct
transaction CWK Ordinary Shares Options Exercise $0 +20,787 +10% $0.000000 219,335 24 Feb 2024 Direct F1
transaction CWK Ordinary Shares Tax liability $70,596 -7,189 -3.3% $9.82 212,146 24 Feb 2024 Direct
transaction CWK Ordinary Shares Options Exercise $0 +17,759 +8.4% $0.000000 229,905 25 Feb 2024 Direct F1
transaction CWK Ordinary Shares Tax liability $86,465 -8,805 -3.8% $9.82 221,100 25 Feb 2024 Direct
transaction CWK Ordinary Shares Options Exercise $0 +46,208 +21% $0.000000 267,308 25 Feb 2024 Direct F2
transaction CWK Ordinary Shares Tax liability $156,973 -15,985 -6% $9.82 251,323 25 Feb 2024 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CWK Restricted Stock Units Options Exercise $0 -34,878 -33% $0.000000 69,756 23 Feb 2024 Ordinary Shares 34,878 Direct F1, F3
transaction CWK Restricted Stock Units Options Exercise $0 -20,787 -50% $0.000000 20,787 24 Feb 2024 Ordinary Shares 20,787 Direct F1, F4
transaction CWK Restricted Stock Units Options Exercise $0 -17,759 -100% $0.000000* 0 25 Feb 2024 Ordinary Shares 17,759 Direct F1, F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Conversion of previously awarded restricted stock units ("RSUs") into an equal number of ordinary shares, without the payment of any consideration, pursuant to the Amended & Restated Cushman & Wakefield plc 2018 Omnibus Management Share and Cash Incentive Plan (the "A&R Omnibus Plan").
F2 Represents vesting of ordinary shares earned in respect of performance-based RSUs based on the achievement by the Issuer of certain performance targets for the 2021-2023 performance period pursuant to the A&R Omnibus Plan.
F3 RSUs were granted on February 23, 2023 and vest in three (3) equal installments on each of the first three (3) anniversaries of the grant date, subject, with certain limited exceptions, to the reporting person's continuing employment through each such vesting date.
F4 RSUs were granted on February 24, 2022 and vest in three (3) equal installments on each of the first three (3) anniversaries of the grant date, subject, with certain limited exceptions, to the reporting person's continuing employment through each such vesting date.
F5 RSUs were granted on February 25, 2021 and vest in three (3) equal installments on each of the first three (3) anniversaries of the grant date, subject, with certain limited exceptions, to the reporting person's continuing employment through each such vesting date.

Remarks:

Global President & Chief Operating Officer Exhibit 24 - Power of Attorney